H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.6% of adults in Jersey City have diagnosed diabetes — 2.4 points below the U.S. 12% figure. Census population 292,449. New Jersey Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Jersey City clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Jersey City storefront.
Advanced Wound Care for Your Clinic in Jersey City, NJ for clinics & physicians. Advanced wound care solut… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 14.6% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 9.6% of adults in Jersey City have diagnosed diabetes — 2.4 points below the U.S. 12% figure. Together those PLACES numbers are why a city of 250k–500k still needs separate PRP and CTP protocols. advanced wound care clinic inventory is national; utilization is JL-local.
National Advanced Wound Care for Your Clinic notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Jersey City we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 9.6% of adults in Jersey City have diagnosed diabetes — 2.4 points below the U.S. 12% figure.
If you already buy advanced wound care clinic elsewhere, use this page as a check: homologous-use language, current Novitas Solutions article IDs, and PLACES 9.6% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 9.6% of adults — 2.4 points below the U.S. 12% figure. Obesity is 26.2%; arthritis is 14.6%. That is place-level BRFSS modeling, not a clinic census and not a Jersey City trial.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
No. /kw pages explain distribution options. Protocol, privilege, and informed consent remain with the licensed New Jersey clinician.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a New Jersey compliance risk.
Ask for the IFU, the lot-traceability packet, and the Novitas Solutions article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Jersey City fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Jersey City, NJ.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Jersey City is JL geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Jersey City — 2.4 points below the U.S. 12% figure. Planning input, not an outcomes claim.
New Jersey Part B wound biologics follow this contractor (siblings: DC, DE, MD, PA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Jersey City. Useful for joint-program math; still needs a diagnosis and privileging.
No Jersey City storefront. Joe Bradley is an active practice owner. advanced wound care clinic stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.